11h
HealthDay on MSNGLP-1 medications show promise in slowing kidney disease progressionThese and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...
Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for diabetic kidney disease, a recent observational study found.
More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...
Chronic kidney disease (CKD) is a growing global health concern, significantly contributing to morbidity and mortality rates worldwide. Characterized by a ...
Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.
1don MSN
A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...
Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.
Chronic kidney disease has been linked to yo-yo dieting (also known as body-weight cycling) in the general population, which ...
7d
Verywell Health on MSNDoctors Can Now Prescribe Ozempic to Reduce Kidney Disease Risks in Diabetes PatientsThe FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.
7d
News Medical on MSNYo-yo dieting found to harm kidney health in type 1 diabetes patientsBody-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, regardless of body mass index (BMI) and other ...
The Food and Drug Administration has approved Ozempic ® (semaglutide) to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, and cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results